Dr. Haris Inam Mirza, MD

Dr. Mirza practices at Ocala Infectious Disease and Wound Center, Inc in Leesburg, Florida.

Dr. Mirza's NPI, 1912956335, was assigned on May 10, 2006. Dr. Mirza graduated from King Edward Medical University in 1992. Dr. Mirza holds Florida license ME88195.

Dr. Mirza's primary practice is Ocala Infectious Disease and Wound Center, Inc, at 620 S Lake St, Leesburg, FL 34748 in Lake County. The practice phone is (352) 401-7552.

Dr. Mirza's primary practice is Ocala Infectious Disease and Wound Center, Inc in Leesburg, Florida. Dr. Mirza is also affiliated with HCA Florida Ocala Hospital. The medical group on file is Ocala Infectious Disease and Wound Center. Dmand AI also links Dr. Mirza to 1 more hospital, 4 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mirza practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Mirza's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Mirza is board certified in infectious disease by the American Board of Internal Medicine. Dr. Mirza is licensed in Florida.

Dmand AI lists acute skin infection, bronchitis, cold sores or genital herpes, hiv/aids, immune deficiency disease, joint or bone infection, lyme disease and pneumonia among the conditions Dr. Mirza treats.

CMS data shows 345,410 Medicare services from Dr. Mirza across 35 procedure codes in 2024, for 649 Medicare patients. Medicare paid $1,189,938 for them.

CMS counts 649 Medicare patients who saw Dr. Mirza in 2024. The largest group is 75 to 84, with 257 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mirza's median patient age at 71, with 52% women.

In 2024, Dr. Mirza wrote 2,330 Medicare Part D claims for 295 patients. 86% of them were for generic drugs. CMS names the drug for 1,909 of them, across 49 drugs with 11 or more claims each, at $643,257 in total drug cost. In 2023, CMS named 2,093 claims across 50 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Mirza for performance year 2024, reported as part of a group. Dr. Mirza accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mirza as offering telehealth. CMS counts 1,970 procedures of removal of tissue by Dr. Mirza, more than 99% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Mirza, published from 2010 to 2015. The most frequent topics are Blastocystis, Caco-2 Cells and Drug Resistance.

CMS Open Payments shows 714 general payments to Dr. Mirza from 56 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Gilead Sciences, Inc. paid the most, $2,794.

Dr. Mirza graduated from King Edward Medical University in 1992.

Dr. Mirza is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.